[PDF][PDF] The pathophysiology of polycystic ovary syndrome

T Tsilchorozidou, C Overton, GS Conway - Clinical endocrinology, 2004 - academia.edu
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of uncertain aetiology,
which affects between 6 and 10% of women of the reproductive age. The heterogeneity of …

[HTML][HTML] Polycystic ovary syndrome: current status and future perspective

EK Barthelmess, RK Naz - Frontiers in bioscience (Elite edition), 2014 - ncbi.nlm.nih.gov
Polycystic ovary syndrome (PCOS) is a widespread reproductive disorder that encompasses
many associated health conditions and has an impact on various metabolic processes …

[图书][B] Polycystic ovary syndrome: current controversies, from the ovary to the pancreas

A Dunaif, RJ Chang, S Franks, RS Legro - 2008 - books.google.com
All four editors of this title are extremely prominent in the field of PCOS. Although they are all
US-based, they are internationally renowned. The book includes the latest diagnostic criteria …

Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

HF Escobar-Morreale - Nature Reviews Endocrinology, 2018 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …

Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

E Diamanti-Kandarakis - Expert Reviews in molecular medicine, 2008 - cambridge.org
Polycystic ovarian syndrome (PCOS) is universally recognised as the commonest
endocrinopathy of women. The definition and the aetiological hypotheses of PCOS are …

Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome

H Lee, JY Oh, YA Sung, H Chung, HL Kim… - Human …, 2015 - academic.oup.com
STUDY QUESTION Are there any novel genetic markers of susceptibility to polycystic ovary
syndrome (PCOS)? SUMMARY ANSWER We identified a novel susceptibility locus on …

Polycystic ovary syndrome phenotypes and prevalence: differential impact of diagnostic criteria and clinical versus unselected population

S Mumusoglu, BO Yildiz - Current Opinion in Endocrine and Metabolic …, 2020 - Elsevier
Polycystic ovary syndrome (PCOS) is the most prevalent endocrine–metabolic disorder,
affecting 6–10% of reproductive-aged women worldwide. The features of PCOS are clinical …

The genetics of the polycystic ovary syndrome

M Urbanek - Nature clinical practice Endocrinology & metabolism, 2007 - nature.com
Polycystic ovary syndrome (PCOS) is a very common endocrine disorder that has a strong
genetic component and is characterized by polycystic ovaries, hyperandrogenemia, and …

[HTML][HTML] Introduction: determinants of polycystic ovary syndrome

R Azziz - Fertility and sterility, 2016 - Elsevier
The polycystic ovary syndrome (PCOS) is recognized as one of the most common endocrine
abnormalities of humans, with global prevalences so far generally 5%–15%. Overall, the …

PCOSKB: A KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic Ovary Syndrome

S Joseph, RS Barai, R Bhujbalrao… - Nucleic acids …, 2016 - academic.oup.com
Polycystic ovary syndrome (PCOS) is one of the major causes of female subfertility
worldwide and≈ 7–10% of women in reproductive age are affected by it. The affected …